Investigating the Role of Antigen Orientation on the Immune Response Elicited by
GMMA
Neisseria meningitidis
conjugation
outer membrane vesicles
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
26 Jul 2022
26 Jul 2022
Historique:
received:
21
06
2022
revised:
15
07
2022
accepted:
16
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
GMMA are outer membrane vesicles (OMVs) released from Gram-negative bacteria genetically modified to enhance OMVs formation that have been shown to be optimal systems to enhance immunogenicity of protein antigens. Here, we selected
Identifiants
pubmed: 35893831
pii: vaccines10081182
doi: 10.3390/vaccines10081182
pmc: PMC9331691
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3304-9
pubmed: 23396847
J Exp Med. 2003 Mar 17;197(6):789-99
pubmed: 12642606
PLoS One. 2015 Aug 06;10(8):e0134478
pubmed: 26248044
J Clin Invest. 2016 Mar 1;126(3):799-808
pubmed: 26928033
Semin Immunol. 2020 Aug;50:101433
pubmed: 33309166
Nat Rev Immunol. 2010 Nov;10(11):787-96
pubmed: 20948547
Biotechnol Adv. 2017 Sep;35(5):565-574
pubmed: 28522212
PLoS One. 2013 Jun 21;8(6):e66536
pubmed: 23805230
Vaccines (Basel). 2020 Sep 17;8(3):
pubmed: 32957610
FASEB J. 2014 Apr;28(4):1644-53
pubmed: 24371123
Expert Rev Vaccines. 2022 Feb;21(2):163-172
pubmed: 34913415
J Infect Dis. 2008 Apr 1;197(7):1053-61
pubmed: 18419542
Infect Immun. 2011 Feb;79(2):887-94
pubmed: 21115718
Comput Struct Biotechnol J. 2015 Nov 26;14:58-68
pubmed: 26862374
J Control Release. 2020 Jul 10;323:253-268
pubmed: 32333919
Sci Rep. 2018 Feb 27;8(1):3700
pubmed: 29487324
J Immunol. 2006 Jun 15;176(12):7566-75
pubmed: 16751403
J Immunol. 2006 Jul 1;177(1):501-10
pubmed: 16785547
Expert Rev Vaccines. 2018 Dec;17(12):1111-1121
pubmed: 30457407
PLoS One. 2017 Jul 25;12(7):e0181508
pubmed: 28742866
Postgrad Med. 2016 Aug;128(6):548-56
pubmed: 27467048
Vaccine. 2003 Feb 14;21(9-10):950-60
pubmed: 12547608
Methods Mol Biol. 2012;799:1-20
pubmed: 21993636
Vaccine. 2014 May 13;32(23):2688-95
pubmed: 24704334
Pathogens. 2021 Jun 09;10(6):
pubmed: 34207575
Infect Immun. 2004 Apr;72(4):2088-100
pubmed: 15039331
Int J Mol Sci. 2021 Sep 22;22(19):
pubmed: 34638530
Microb Pathog. 2019 Sep;134:103571
pubmed: 31163252
Infect Immun. 2009 Feb;77(2):764-9
pubmed: 19047406
Int J Mol Sci. 2020 Jun 21;21(12):
pubmed: 32575921
Methods Mol Biol. 2022;2414:227-279
pubmed: 34784041
J Control Release. 2016 Jul 28;234:124-34
pubmed: 27221070
Front Immunol. 2021 Aug 03;12:715393
pubmed: 34413858
Front Immunol. 2021 Sep 14;12:719315
pubmed: 34594333
J Immunol. 2004 May 1;172(9):5606-15
pubmed: 15100304
Nat Commun. 2020 Oct 5;11(1):4994
pubmed: 33020485
Sci Rep. 2016 Nov 16;6:37242
pubmed: 27849050
Sci Rep. 2012;2:341
pubmed: 22461972
Expert Rev Vaccines. 2015 Jun;14(6):841-59
pubmed: 25704037
Bioconjug Chem. 2018 May 16;29(5):1736-1747
pubmed: 29697244
Vaccine. 2010 Aug 23;28(37):6086-93
pubmed: 20619376
Biotechnol J. 2019 Jan;14(1):e1800376
pubmed: 30537361
Infect Immun. 2005 Feb;73(2):1151-60
pubmed: 15664958
J Biol Chem. 2009 Apr 3;284(14):9022-6
pubmed: 19196709
Vaccines (Basel). 2021 Jan 29;9(2):
pubmed: 33572803
Pediatrics. 2016 Sep;138(3):
pubmed: 27573083
Vaccine. 2009 Jun 24;27 Suppl 2:B3-12
pubmed: 19481313
J Extracell Vesicles. 2013 May 06;2:
pubmed: 24009891
Front Microbiol. 2018 Apr 26;9:783
pubmed: 29755431
Infect Immun. 2008 Sep;76(9):4232-40
pubmed: 18591239
Biotechnol J. 2015 Sep;10(11):1689-706
pubmed: 26912077